Compare W & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | W | BAX |
|---|---|---|
| Founded | 2002 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 13.9B |
| IPO Year | 2014 | 1994 |
| Metric | W | BAX |
|---|---|---|
| Price | $112.02 | $24.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 33 | 15 |
| Target Price | ★ $125.41 | $27.08 |
| AVG Volume (30 Days) | 1.9M | ★ 6.6M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | ★ 39.15 | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $7.82 | $4.07 |
| Revenue Next Year | $7.41 | $1.88 |
| P/E Ratio | ★ N/A | $30.93 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $55.60 | $15.73 |
| 52 Week High | $122.13 | $30.00 |
| Indicator | W | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 47.55 |
| Support Level | $95.43 | $23.62 |
| Resistance Level | $118.31 | $25.99 |
| Average True Range (ATR) | 5.29 | 0.96 |
| MACD | -0.13 | -0.15 |
| Stochastic Oscillator | 37.20 | 45.08 |
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. The firm offers more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.